ACR: T2T works in the real world


The likelihood of achieving remission based on ACR/EULAR criteria is 52 percent higher when a patient with RA is treated to target, real world data presented at ACR15 shows. Results from the BIODAM study led by Sofia Ramiro, Leiden University Medical Center in the Netherlands also found that treat-to-target-strategies (remission and low disease activity) led ...


Already a member? Login to keep reading


OR
© 2017 the limbic